Given that PLA2G7 has been reported to increase cancer cell migration, and PLA2G7 knockdown by siRNA led to reduced cancer cell migration [19], we next evaluated the inhibition of PLA2G7-mediated cell migration by our anti-PLA2G7 antibodies on both HCT116 and HT29 cells. Here, PLA2G7 is linked to cancer.